SCHEMBL16626402

SCHEMBL16626402

CNCc1cn(S(=O)(=O)c2cccnc2)c2cc(Nc3cccc(C)c3F)ccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDE P14735 2/20 0.36
HTR6 P50406 6/20 0.35
ALK Q9UM73 1/20 0.34
TBXAS1 P24557 1/20 0.34
CYP19A1 P11511 1/20 0.33
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33
FGFR4 P22455 1/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2B Q13224 1/20 0.33
NAMPT P43490 1/20 0.33
CHRNB2 P17787 1/20 0.32
CHRNB4 P30926 1/20 0.32
CHRNA3 P32297 1/20 0.32
CHRNA4 P43681 1/20 0.32
SLC40A1 Q9NP59 1/20 0.32
FBP1 P09467 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16618935 0.99 IDE (0.36) IDEHTR6ALKTBXAS1CYP19A1
SCHEMBL16626437 0.93 IDE (0.36) IDEHTR6ALKTBXAS1CYP19A1
Hydrochloric Acid SCHEMBL16618656 0.92 IDE (0.36) IDEHTR6ALKTBXAS1CYP19A1
SCHEMBL16626454 0.89 IDE (0.38) IDEHTR6ALKTBXAS1CYP19A1
SCHEMBL16626696 0.89 IDE (0.37) IDEHTR6TBXAS1CYP19A1PDE4A
SCHEMBL16626680 0.89 CHRNB2 (0.41) IDEHTR6TBXAS1CYP19A1FGFR4
SCHEMBL16626462 0.88 IDE (0.38) IDEHTR6ALKTBXAS1CYP19A1
Hydrochloric Acid SCHEMBL16618791 0.88 IDE (0.38) IDEHTR6ALKTBXAS1CYP19A1
SCHEMBL16626417 0.88 ALDH1A1 (0.40) IDEHTR6TBXAS1CYP19A1NAMPT
Hydrochloric Acid SCHEMBL16618997 0.88 IDE (0.36) IDEHTR6TBXAS1CYP19A1PDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP claimed
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP disclosed
US-9676714-B2 Sulfonylindole derivatives and method for preparing the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2017-06-13 US disclosed
US-9676714-B2 Sulfonylindole derivatives and method for preparing the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2017-06-13 US disclosed
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-08-04 US disclosed
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-08-04 US disclosed
WO-2015050412-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME GIPR, PGC, SI IDE 2586/4885HTR6 166/4885ALK 4825/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.